Command Medical Products

Medical device manufacturer.

Based in FL

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $20K in lobbying spend across 2 quarterly filings, Command Medical Products is an active lobbying client. Their lobbying covers 1 issue area.

$20K
Total Spend
1
Years Active
1
Firms Hired
3
Lobbyists Deployed
1
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2025$20K

Issues Lobbied

Trade

Lobbying Firms

Akin Gump Strauss Hauer & Feld

Lobbyists

Cara MorrowGeoff VerhoffBrian Pomper

Government Agencies Targeted

These are the government entities that Command Medical Products disclosed contacting in their lobbying filings.

SENATEU.S. Trade Representative (USTR)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Trade

Issues related to Section 301 investigation on Nicaragua.

Issues related to Nicaragua Section 301 investigation.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Carrier Global Corporation
$13.6M total spend
Apotex Corp.
$9.0M total spend
Bacardi North America (Formerly Bacardi USA INC)
$4.3M total spend
U.S Sugar Corporation
$3.8M total spend
Mitsubishi Power Americas INC F/K/A Mhps Americas INC
$2.6M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.